The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Honoraria - UroToday
Consulting or Advisory Role - UroToday
Effect of a genomic classifier on adjuvant treatment decision-making among patients with high-risk pathology at radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.
 
John L. Gore
No Relationships to Disclose
 
Marguerite Du Plessis
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
 
Maria Santiago-Jimenez
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
 
Kasra Yousefi
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
 
Darby J. S. Thompson
Consulting or Advisory Role - GenomeDx (Inst)
 
David Y. T. Chen
No Relationships to Disclose
 
William R. Clark
Research Funding - GenomeDx (Inst)
 
Michael E. Franks
Speakers' Bureau - Astellas Pharma
 
Lawrence Ivan Karsh
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Genomic Health (Inst); Janssen (Inst); Medivation (Inst); Spectrum Pharmaceuticals (Inst)
 
Adam S. Kibel
Honoraria - Dendreon; MTG Therapeutics; profound; Sanofi; Tokai Pharmaceuticals
 
Hyung Lae Kim
No Relationships to Disclose
 
Brian R. Lane
No Relationships to Disclose
 
Yair Lotan
Consulting or Advisory Role - MDxhealth; Physical Optics Corporation; SonaCare Medical
Research Funding - Abbott Molecular; Cepheid; Danone; Metabolon; pacific edge
 
William Thomas Lowrance
Consulting or Advisory Role - MDxHealth
Research Funding - Argos Therapeutics (Inst); GenomeDx (Inst); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - MDxHealth
 
Paul Maroni
Research Funding - GenomeDx
 
Scott David Perrapato
No Relationships to Disclose
 
Edouard John Trabulsi
No Relationships to Disclose
 
Robert J. Waterhouse
Employment - Carolina Urology Partners
Leadership - Carolina Urology Partners
Stock and Other Ownership Interests - Carolina Urology Partners
Honoraria - Astellas Pharma; Myriad Genetics
Consulting or Advisory Role - Astellas Pharma; Myriad Genetics
Speakers' Bureau - Astellas Pharma; Myriad Genetics
Research Funding - Allergan; Argos Therapeutics; Astellas Pharma; Boston Scientific; Cogentix Medical; Coloplast; Dendreon; GenomeDx; Genomic Health; MDxHealth; Medivation; Myriad Genetics; Orion
Travel, Accommodations, Expenses - Astellas Pharma; Myriad Genetics
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma
Research Funding - Genomic Health; Myriad Genetics